Healthcare distributor and services company McKesson (NYSE:MCK) will be reporting results this Wednesday after market close.

Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up ...

Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up ...

Experts debate which patients with stage III dMMR colon cancer will benefit from the two treatment approaches.

According to TipRanks.com, Block is a 4-star analyst with an average return of 5.2% and a 49.7% success rate. Block covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, ...

The global Liquid Biopsy Market, valued at US$3.65 billion in 2024 stood at US$4.03 billion in 2025 and is projected to ...

According to Research by SNS Insider, Global Laboratory Developed Tests Market Growth is Fueled by Rising Demand for Personalized Diagnostics and Chronic Disease Detection.Austin, Aug. 05, 2025 (GLOBE ...